Provided by Tiger Fintech (Singapore) Pte. Ltd.

NeuroPace Inc.

12.23
-0.7800-6.00%
Post-market: 12.230.00000.00%17:47 EDT
Volume:221.31K
Turnover:2.69M
Market Cap:398.21M
PE:-13.12
High:12.68
Open:12.40
Low:11.83
Close:13.01
Loading ...

NeuroPace $65M Spot Secondary expected to price at $10

TIPRANKS
·
14 Feb

NeuroPace announces $65M common stock offering

TIPRANKS
·
14 Feb

Neuropace Announces Proposed Public Offering of $65 Million of Common Stock

THOMSON REUTERS
·
14 Feb

NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock

GlobeNewswire
·
14 Feb

Neuropace Announces Upcoming Oral Presentation of Data From the Post-Approval Study of the Rns System at the American Academy of Neurology 2025 Annual Meeting Being Held April 5TH – 9TH

THOMSON REUTERS
·
04 Feb

NeuroPace Announces Upcoming Oral Presentation of Data from the Post-Approval Study of the RNS System at the American Academy of Neurology 2025 Annual Meeting Being Held April 5th – 9th

GlobeNewswire
·
04 Feb

NeuroPace Is Maintained at Overweight by Wells Fargo

Dow Jones
·
31 Jan

NeuroPace: Strategic Growth and Market Expansion Drive Positive Outlook

TIPRANKS
·
30 Jan

NeuroPace: Strong Growth Trajectory and Upcoming Catalysts Justify Buy Rating

TIPRANKS
·
30 Jan

Cantor Fitzgerald Sticks to Their Buy Rating for NeuroPace (NPCE)

TIPRANKS
·
29 Jan

NeuroPace price target raised to $19 from $18 at Cantor Fitzgerald

TIPRANKS
·
29 Jan

NeuroPace Expects 2025 Revenue Growth

MT Newswires Live
·
29 Jan

NeuroPace Projects 2025 Growth and Product Enhancements

TIPRANKS
·
29 Jan

Neuropace, Inc. Outlook FY Gross Margin 73-75%

THOMSON REUTERS
·
29 Jan

Neuropace Inc: Three-Year Targets of 20% Revenue Cagr and Achievement of Cash Flow Breakeven

THOMSON REUTERS
·
29 Jan

Neuropace Issues 2025 Financial Guidance Targets

THOMSON REUTERS
·
29 Jan

NeuroPace Issues 2025 Financial Guidance Targets

GlobeNewswire
·
29 Jan

Lake Street Remains a Buy on NeuroPace (NPCE)

TIPRANKS
·
24 Jan

NeuroPace, Inc. (NASDAQ:NPCE) Looks Just Right With A 26% Price Jump

Simply Wall St.
·
24 Jan

NeuroPace (NPCE) Soars 9.1%: Is Further Upside Left in the Stock?

Zacks
·
22 Jan